Potential indications: uveitis, psoriasis, psoriatic arthritis

describe

1. For the treatment of non infective uveitis.

2. Through target antagonism, it can inhibit the inflammatory cascade and achieve the effect of treating uveitis.

3. Compared with traditional antibody drugs, its products have higher affinity and lower molecular weight; HSA nano antibody binds to endogenous HSA, and the half-life is significantly prolonged.